Jeff E. Knight, Chief Operating Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 13,963 shares at $34.17 ($477K) on 2025-03-19, disclosed to the SEC on 2025-03-21.
Scheduled sale ($477k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.17 | 6,801 | $232K | 48.7% |
| 2 | $34.17 | 6,801 | $232K | 48.7% |
| 3 | $34.83 | 361 | $13K | 2.6% |
| Total | $34.19 avg | 13,963 | $477K | 100% |
| Filing → |
| CRNX | SELL | 2024-11-26 | $28K | — | Filing → |
| CRNX | SELL | 2024-07-17 | $1.5M | — | Filing → |
| CRNX | SELL | 2024-06-28 | $42K | — | Filing → |